Natixis Grows Holdings in SPDR S&P Biotech ETF (XBI)

Natixis boosted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.5% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 49,498 shares of the exchange traded fund’s stock after purchasing an additional 2,594 shares during the quarter. Natixis owned about 0.09% of SPDR S&P Biotech ETF worth $4,712,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in XBI. Rockefeller Capital Management L.P. purchased a new position in SPDR S&P Biotech ETF during the 2nd quarter worth $130,000. WP Advisors LLC purchased a new position in SPDR S&P Biotech ETF during the 2nd quarter worth $133,000. Trust Co. of Vermont purchased a new position in SPDR S&P Biotech ETF during the 2nd quarter worth $136,000. Squar Milner Financial Services LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at $139,000. Finally, Valeo Financial Advisors LLC increased its holdings in shares of SPDR S&P Biotech ETF by 165.2% in the 2nd quarter. Valeo Financial Advisors LLC now owns 1,525 shares of the exchange traded fund’s stock valued at $144,000 after acquiring an additional 950 shares during the period.

Shares of NYSEARCA:XBI opened at $95.83 on Friday. SPDR S&P Biotech ETF has a 12-month low of $78.46 and a 12-month high of $101.55.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Further Reading: Short Selling Stocks, A Beginner’s Guide

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply